Curium Pharma

Curium Pharma, operating as BioM, specializes in the manufacturing and distribution of radiopharmaceuticals for Positron Emission Tomography (PET) imaging. Their primary products include ¹⁸F-Fluorodeoxyglucose (¹⁸F-FDG) and Sodium Fluoride ¹⁸F Injection, which are used as diagnostic agents to visualize metabolic activity and bone abnormalities, respectively. The company manages the entire process from order to delivery, supporting medical diagnostic procedures.